Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular Imaging of Myocardial Fibrosis in Cardiac Amyloidosis
NCT05619302Phase 3Active, not recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Gallium Ga 68 NODAGA-CBP8 in cardiac amyloidosis, sponsored by Brigham and Women's Hospital. Started Jan 2023; status: active, not recruiting.
02
Drugs
Gallium Ga 68 NODAGA-CBP8
03
Conditions
cardiac amyloidosis
Beyond the preview
Go deeper on NCT05619302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05619302.